High Quality Tranilast CAS 53902-12-8

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 60/gram
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
10000000 RMB
Plant Area
101~500 square meters
  • High Quality Tranilast CAS 53902-12-8
  • High Quality Tranilast CAS 53902-12-8
  • High Quality Tranilast CAS 53902-12-8
  • High Quality Tranilast CAS 53902-12-8
  • High Quality Tranilast CAS 53902-12-8
  • High Quality Tranilast CAS 53902-12-8
Find Similar Products

Basic Info.

Model NO.
Tranilast
Suitable for
Elderly, Children, Adult
State
Light-Yellow Crystal or Crys
Purity
>99%
CAS
53902-12-8
Mf
C18h17no5
MW
327.33
Grade
Phamaceutical Grade
Melting Point
153-154c
Storage
Cool Dry Place
Shelf Life
24 Months
Transport Package
1kg/Bag, 25kg/Drum
Specification
Tranilast
Trademark
HNB
Origin
China
Production Capacity
500kg/Month

Product Description

High Quality Tranilast CAS 53902-12-8
product Name
Tranilast
Molecular Formula
C18H17NO5
Molecular Weight
327.33
CAS Registry Number
53902-12-8
Melting point
153-154ºC
Boiling point
154.5°C
Refractive index
Keep in a cool, dry, dark location
Flash point
24 months when properly stored

Tranilast is a compound that exhibits anti-inflammatory and immunomodulatory effects by inhibiting lipid mediator and cytokine release from inflammatory cells and interfering with PDGF- and TGF-β1-induced proliferation and migration of vascular medial smooth muscle cells. Tranilast suppresses production of prostaglandin D2 (IC50 = 0.1 mM), prostaglandin E2 (IC50 = ~1-20 μM), thromboxane B2 (IC50 = ~10-50 μM), TGF-β1 (IC50 = ~100-200 μM), and interleukin-8 (IC50 = ~100 μM) in in vitro models as well as attenuates of the proinflammatory activity of human monocytes. While originally marketed as an antiallergenic drug, the efficacy of tranilast in preventing restenosis after percutaneous coronary intervention has been tested in a large-scale clinical trial.
Additionally, tranilast inhibits VEGF-induced angiogenetic activities (i.e., proliferation, migration and tube formation of
vascular endothelial cells) with IC50 values of 22, 18 and 193 μM, which may prove therapeutic for various retinal
diseases.


High Quality Tranilast CAS 53902-12-8

High Quality Tranilast CAS 53902-12-8
Items
Specification
Appearance
Light yellow or light-yellow green crystal or crystalline powder
Assay
≥98.5%
Melting point
207-210°C
Identification:
1)It appears positive reaction
2)Maximum absorbability at 333nm Wavelength Minimum absorbability at 263nm Wavelength
3)Complies
Chloride
Conform
Relevant material
Conform
Loss on drying
≤0.5%
Residue on ignition
≤0.1%
Heavy metals
≤15ppm
Microbe limitation
Conform

High Quality Tranilast CAS 53902-12-8High Quality Tranilast CAS 53902-12-8High Quality Tranilast CAS 53902-12-8High Quality Tranilast CAS 53902-12-8High Quality Tranilast CAS 53902-12-8High Quality Tranilast CAS 53902-12-8High Quality Tranilast CAS 53902-12-8

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier